Osteogenic gene expression correlates with development of heterotopic ossification in war wounds

Clinical Orthopaedics and Related Research

Volumn 472, Issue 2, 2014, Pages 396-404

  Evans, Korboi N ^a,b   Potter, Benjamin K ^b,c   Brown, Trevor S ^a   Davis, Thomas A ^a   Elster, Eric A ^a,b,c   Forsberg, Jonathan A ^a,b,c  

^a NAVAL MEDICAL RESEARCH CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c Uniformed Services University of the Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CARTILAGE OLIGOMERIC MATRIX PROTEIN; COL11A1 PROTEIN; COL2A1 PROTEIN; COLL10A1; COLLAGEN TYPE 10; COLLAGEN TYPE 11; COLLAGEN TYPE 2; CSF2 PROTEIN; CSF3 PROTEIN; GELATINASE B; MESSENGER RNA; NEUTROPHIL COLLAGENASE; OSTEOGENIN; SMAD1 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADULT; ARTICLE; BATTLE INJURY; BONE BIOPSY; BONE DEVELOPMENT; CONTROLLED STUDY; DEBRIDEMENT; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HETEROTOPIC OSSIFICATION; HUMAN; HUMAN TISSUE; MALE; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; UPREGULATION;

ADOLESCENT; ADULT; AFGHAN CAMPAIGN 2001-; BIOPSY; BONE MORPHOGENETIC PROTEIN 2; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; IRAQ WAR, 2003-2011; MALE; MILITARY MEDICINE; MILITARY PERSONNEL; OSSIFICATION, HETEROTOPIC; OSTEOGENESIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION; WOUNDS, PENETRATING; YOUNG ADULT;

EID: 84893645277     PISSN: 0009921X     EISSN: 15281132     Source Type: Journal    
DOI: 10.1007/s11999-013-3325-8     Document Type: Article

References (53)

1. Allori RC, Sailon AM, Warren SM. Biological basis of bone formation, remodeling, and repair - part I: biochemical signaling molecules. Tissue Eng Part B Rev. 2008;14:259-273.
2. Bidner SM, Rubins IM, Desjardins JV, Zukor DJ, Gotzman D. Evidence for a humoral mechanism for enhanced osteogenesis after head injury. J Bone Joint Surg Am. 1990;55:1144-1149.
3. Brooker AF, Bowerman JW, Robinson RA, Riley LHJ. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55:1629-1632.
4. Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion. J Bone Joint Surg Br. 2003;85:700-705.
5. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today. 2003;8:980-989.
6. Champagne CM, Takebe J, Offenbacher S, Cooper LF. Macrophage cell lines produce osteoinductive signals that include bone morphogenetic protein-2. Bone. 2002;30:26-31.
7. Chan KT. Heterotopic ossification in traumatic brain injury. Am J Phys Med Rehabil. 2005;84:145-146.
8. Chandrasenan J, Dias R, Lunn PG. Heterotopic ossification after the Outerbridge-Kashiwagi procedure in the elbow. J Shoulder Elbow Surg. 2008;17:15-17.
9. Chen D, zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors. 2004;22:233-241.
10. Davis TA, O'Brien FP, Anam K, Grijalva S, Potter BK, Elster EA. Heterotopic ossification in complex orthopaedic combat wounds: quantification and characterization of osteogenic precursor cell activity in traumatized muscle. J Bone Joint Surg Am. 2011;93:1122-1131.
11. de la Pena LS, Billings PC, Fiori JL, Ahn J, Kaplan FS, Shore EM. Fibrodysplasia ossificans progressiva (FOP), a disorder of ectopic osteogenesis, misregulates cell surface expression and trafficking of bmpria. J Bone Miner Res. 2005;20:1168-1176.
12. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos SE, Lowik CW. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology. 2000;141:1667-1674.
13. Ekelund A, Brosjo O, Nilsson OS. Experimental induction of heterotopic bone. Clin Orthop Relat Res. 1991;263:102-112.
14. Emans PJ, Spaapen F, Surtel DA, Reilly KM, Cremers A, Van Rhijn LW, Bulstra SK, Voncken JW, Kuijer R. A novel in vivo model to study endochondral bone formation; HIF-1alpha activation and bmp expression. Bone. 2007;40:409-418.
15. Evans KN, Forsberg JA, Potter BK, Hawksworth JS, Brown TS, Andersen R, Dunne JR, Tadaki D, Elster EA. Inflammatory cytokine and chemokine expression is associated with heterotopic ossification in high-energy penetrating war injuries. J Orthop Trauma. 2012;26:e204-13.
16. Forsberg JA, Pepek JM, Wagner S, Wilson K, Flint J, Andersen RC, Tadaki D, Stojadinovic A, Elster EA. Heterotopic ossification in high-energy wartime extremity injuries: incidence and risk factors. J Bone Joint Surg Am. 2009;91:1084-1091.
17. Forsberg JA, Potter BK. Heterotopic ossification in wartime wounds. J Surg Orthop Adv. 2010;19:54-61.
18. Furuya H, Ikezoe K, Wang L, Ohyagi Y, Motomura K, Fujii N, Kira J, Fukumaki Y. A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, g356d, other than the common mutation (r206 h). Am J Med Genet A. 2008;146:459-463.
19. Glaser DL, Economides AN, Wang L, Liu X, Kimble RD, Fandl JP, Wilson JM, Stahl N, Kaplan FS, Shore EM. In vivo somatic cell gene transfer of an engineered noggin mutein prevents BMP4-induced heterotopic ossification. J Bone Joint Surg Am. 2003;85:2332-2342.
20. Groppe JC, Shore EM, Kaplan FS. Functional modeling of th EACVR1 (r206 h) mutation in fop. Clin Orthop Relat Res. 2007;462:87-92.
21. Hassel S, Schmitt S, Hartung A, Roth M, Nohe A, Petersen N, Ehrlich M, Henis YI, Sebald W, Knaus P. Initiation of SMAD-dependent and SMAD-independent signaling via distinct BMP-receptor complexes. J Bone Joint Surg Am. 2003;85(Suppl 3):44-51.
22. Hawksworth JS, Stojadinovic A, Gage FA, Tadaki DK, Perdue PW, Forsberg J, Davis TA, Dunne JR, Denobile JW, Brown TS, Elster EA. Inflammatory biomarkers in combat wound healing. Ann Surg. 2009;250:1002-1007.
23. Kakudo N, Kusumoto K, Wang YB, Iguchi Y, Ogawa Y. Immunolocalization of vascular endothelial growth factor on intramuscular ectopic osteoinduction by bone morphogenetic protein-2. Life Sci. 2006;79:1847-1855.
24. Kan L, Hu M, Gomes WA, Kesler JA. Transgenic mice overexpressing BMP4 develop a fibrodysplasia ossificans progressiva (FOP)-like phenotype. Am J Pathol. 2004;165:1107-1115.
25. Kaplan FS, Glaser DL, Hebela N, Shore EM. Heterotopic ossification. J Am Acad Orthop Surg. 2004;12:116-125.
26. Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, Hoover-Fong J, Koster B, Pauli RM, Reardon W, Zaidi SA, Zasloff MA, Morhart R, Mundlos S, Groppe JC, Shore EM. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1. Hum Mutat. 2008;20:379-390.
27. Kaysinger KK, Ramp WK, Lang GJ, Gruber HE. Comparison of human osteoblasts and osteogenic cells from heterotopic bone. Clin Orthop Relat Res. 1997;342:181-191.
28. Kempen DH, Lu L, Heijink A, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, Dhert WJ. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials. 2009;30:2816-2825.
29. Kim SY, Choi HY, Myung KB, Choi YW. The expression of molecular mediators in the idiopathic cutaneous calcification and ossification. J Cutan Pathol. 2008;35:826-831.
30. Levy AP, Levy NS, Wegner S, Goldberg MA. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem. 1995;270:13333-13340.
31. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c[t]) method. Methods. 2001;25:402-408.
32. Lounev VY, Ramachandran R, Wosczyna MN, Yamamoto M, Maidment AD, Shore EM, Glaser DL, Goldhamer DJ, Kaplan FS. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am. 2009;91:652-663.
33. Madan A, Curtin PT. A 24-base-pair sequence 3′ to the human erythropoetin gene contains a hypoxia-responsive transcriptional enhancer. Proc Natl Acad Sci USA. 1993;90:3928-3932.
34. Moed BR, Karges DE. Prophylactic indomethacin for the prevention of heterotopic ossification after acetabular fracture surgery in high-risk patients. J Orthop Trauma. 1994;8:34-39.
35. Moore TJ. Functional outcome following surgical excision of heterotopic ossification in patients with traumatic brain injury. J Orthop Trauma. 1993;7:11-14.
36. Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K. Temporal and spatial expression profiles of bmp receptors and noggin during BMP-2-induced ectopic bone formation. J Bone Miner Res. 2003;18:1854-1862.
37. Nesti LJ, Jackson WM, Shanti RM, Koehler SM, Aragon AB, Bailey JR, Sracic MK, Freedman BA, Giuliani JR, Tuan RS. Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue. J Bone Joint Surg Am. 2008;90:2390-2398.
38. Olmsted-Davis E, Gannon FH, Ozen M, Ittmann MM, Gugala Z, Hipp JA, Moran KM, Fouletier-Dilling CM, Schumara-Martin S, Lindsey RW, Heggeness MH, Brenner MK, Davis AR. Hypoxic adipocytes pattern early heterotopic bone formation. Am J Pathol. 2007;170:620-632.
39. Potter BK, Burns TC, Lacap AP, Granville RR, Gajewski DA. Heterotopic ossification following traumatic and combat-related amputations. Prevalence, risk factors, and preliminary results of excision. J Bone Joint Surg Am. 2007;89:476-486.
40. Reginato AM, Sanz-Rodriguez C, Jimenez SA. Biosynthesis and characterization of type x olalgen in human fetal epiphyseal growth plate cartilage. Osteoarthritis Cartilage. 1995;3:105-116.
41. Rifas L, Cheng SL, Shen V, Peck WA. Monokines produced by macrophages stimulate the growth of osteoblasts. Connect Tissue Res. 1989;23:163-178.
42. Samee M, Kasugai S, Kondo H, Ohya K, Shimokawa H, Kuroda S. Bone morphogenetic protein-2 (BMP-2) and vascular endotheslial growth factor (VEGF) transfection to human periosteal cells enhances osteoblastic differentiation and bone formation. J Pharmacol Sci. 2008;108:18-31.
43. Sandberg M, Autio-Harmainen H, Vuorio E. Localization of the expression of types I, III, and IV collagen, TGF-beta 1 and c-FOS genes in developing human calvarial bones. Dev Biol. 1988;130:324-334.
44. Sawyer JR, Myers MA, Rosier RN, Puzas JE. Heterotopic ossification: clinical and celluar aspects. Calcif Tissue Int. 1991;49:208-215.
45. Sell S, Gaissmaier C, Fritz J, Herr G, Esenwein S, Kusswetter W, Volkmann R, Wittkowski KM, Rodermann HP. Different behavior of human osteoblast-like cells isolated from normal and heterotopic bone in vitro. Calcif Tissue Int. 1998;62:51-59.
46. Shafritz AB, Shore EM, Gannon FH, Zasloff MA, Taub R, Muenke M, Kaplan FS. Overexpression of an osteogenic morphogen in fibrodysplasia ossificans progressiva. N Engl J Med. 1996;335:555-561.
47. Shi X, Yang X, Chen D, Chang Z, Cao X. SMAD1 interacts with homeobox DNA-binding proteins in bone morphogenetic protein signaling. J Biol Chem. 1999;274:13711-13717.
48. Shore EM, Glaser DL, Gannon FH. Osteogenic induction in hereditary disorders of heterotopic ossification. Clin Orthop Relat Res. 2000;374:303-316.
49. Simonsen LL, Sonne-Holm S, Krasheninnikoff M, Engberg AW. Symptomatic heterotopic ossification after very severe traumatic brain injury in 114 patients: incidence and risk factors. Injury. 2007;38:1146-1150.
50. Sun X, Wei Y. The role of hypoxia-inducible factor in osteogenesis and chondrogenesis. Cytotherapy. 2009;11:261-267.
51. Yeh LC, Lee JC. Osteogenic protein-1 increases gene expression of vascualr endotheslial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol. 1999;153:113-124.
52. Yin M, Gentili C, Koyama E, Zasloff MA, Pacifici M. Antiangiogenic treatment delays chondrocyte maturation and bone formation during limb skeletogenesis. J Bone Miner Res. 2002;17:56-65.
53. Zhang F, Qiu T, Wu X, Wan C, Shi W, Wang YB, Chen J, Wan M, Clemens TL, Cao X. Sustained BMP signaling in osteoblasts stimulates bone formation by promoting angiogenesis and osteoblast differentiation. J Bone Miner Res. 2009;24:1224-1233.